Public Board papers 31.03.22

Executive Objectives 2022/23 1. To demonstrate excellent and equitable clinical outcomes and patient safety, patient experience and clinical effectiveness for those patients living with and beyond cancer Annual objective Measure Timescale Director Progress 1.1 To ensure delivery of the patient and public experience plans To develop and implement a Trust Patient and Public Engagement Strategy 31.3.23 CN&EDoQ 1.2 To support the divisions in the delivery of the Quality Strategy To realise the year 2 goals of the 2022/24 Quality Plan 31.3.23 CN&EDoQ 1.3 To implement the Trust Risk Management Strategy To realise the implementation of strategy objectives: i) launch a

trust-wide revised risk awareness training programme; ii) implementation of ‘Risk Awareness Week’; implementation of Safety II – Learning from Excellence To implement stretch targets for ward CODE re-accreditation scheme assessments. To implement CODE accreditation to ambulatory care, CRF Embed acute and supportive care directorate and clinical leadership Develop Supportive Care strategy to align with LW&BC BRC bid Expand ambulatory care capacity and implement virtual ward To deliver the 2022/23 Capital Plan in line with the ICS Transfer of the management of peripheral outpatient activity Implement the phase 1 of closed loop chemotherapy Enhance patient and staff experience in OP pharmacy services Explore the opportunities to improve patient facilities in CT Implement the ‘Please, Write to Me’ guidance from the Academy of Medical Royal College across all clinical teams

31.3.23

CN&EDoQ

1.4 Ensure all patient care areas provide high quality care and treatment

31.3.23

CN&EDoQ

31.3.23

CN&EDoQ

1.5 Ensure patients receive excellent acute and supportive care

31.3.23

EMD

1.6 To deliver improvements to the patient environment & experience

31.3.23 31.3.23 31.3.23 31.3.23 31.3.23

EDoF&BD

COO COO COO COO

1.7 Improve information provided to patients around their cancer and treatment

31.3.23

EMD

123